Roundview Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,047
| Closed | -$1.29M | – | 346 |
|
|
2024
Q3 | $1.29M | Buy |
+13,047
| New | +$1.29M | 0.09% | 189 |
|
|
2023
Q3 | – | Sell |
-15,126
| Closed | -$1.26M | – | 318 |
|
|
2023
Q2 | $1.26M | Sell |
15,126
-2,109
| -12% | -$175K | 0.12% | 166 |
|
|
2023
Q1 | $1.31M | Buy |
17,235
+2,106
| +14% | +$160K | 0.14% | 158 |
|
|
2022
Q4 | $1.26M | Buy |
15,129
+3,156
| +26% | +$262K | 0.14% | 155 |
|
|
2022
Q3 | $950K | Buy |
11,973
+1,757
| +17% | +$139K | 0.12% | 164 |
|
|
2022
Q2 | $759K | Buy |
10,216
+2,617
| +34% | +$194K | 0.09% | 192 |
|
|
2022
Q1 | $683K | Buy |
7,599
+5,575
| +275% | +$501K | 0.07% | 210 |
|
|
2021
Q4 | $227K | Buy |
+2,024
| New | +$227K | 0.02% | 283 |
|